Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, ...14, 15, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-09-21
4:55 pm
Purchase
13GKura Oncology, Inc.
KURA
Flynn James E4,374,044
5.89%
1,991,044increase
(+83.55%)
View
2023-08-30
08:07 am
Purchase
13GInvitae Corporation
NVTA
Flynn James E93,062,106
4.9%
92,895,440increase
(+55737.49%)
View
2023-08-14
5:07 pm
Sale
13GSingular Genomics Systems, Inc.
OMIC
Flynn James E7,916,655
7.4%
-1,064,216decrease
(-11.85%)
View
2023-06-22
5:46 pm
Purchase
13GVerastem, Inc.
VSTM
Flynn James E1,538,461
6.1%
1,538,461increase
(New Position)
View
2023-06-09
4:15 pm
Sale
13GGeneDx Holdings Corp.
WGS
Flynn James E1,253,895
4.9%
-55,938,206decrease
(-97.81%)
View
2023-05-26
3:09 pm
Purchase
13GCabaletta Bio, Inc.
CABA
Flynn James E2,340,118
5.9%
1,875,866increase
(+404.06%)
View
2023-05-23
5:25 pm
Sale
13DGraybug Vision, Inc.
GRAY
Flynn James E276,798
4.89%
-100,466decrease
(-26.63%)
View
2023-05-18
4:05 pm
Purchase
13GAmedisys, Inc.
AMED
Flynn James E1,794,000
5.51%
1,794,000increase
(New Position)
View
2023-05-10
12:51 pm
Sale
13GRain Therapeutics Inc.
RAIN
Flynn James E0
0%
-2,796,261decrease
(Position Closed)
View
2023-05-03
4:58 pm
Sale
13GMirum Pharmaceuticals, Inc.
MIRM
Flynn James E0
0%
-2,032,335decrease
(Position Closed)
View
2023-04-06
4:50 pm
Purchase
13GOwens & Minor, Inc.
OMI
Flynn James E4,202,667
5.51%
4,202,667increase
(New Position)
View
2023-03-28
09:37 am
Sale
13DGraybug Vision, Inc.
GRAY
Flynn James E377,264
6.84%
-1,336,609decrease
(-77.99%)
View
2023-03-27
4:09 pm
Sale
13DGraybug Vision, Inc.
GRAY
Flynn James E1,713,873
24.49%
-3,567,840decrease
(-67.55%)
View
2023-03-22
4:17 pm
Purchase
13GDeciphera Pharmaceuticals, Inc.
DCPH
Flynn James E4,627,310
6.09%
2,278,082increase
(+96.97%)
View
2023-03-16
5:41 pm
Purchase
13DLarimar Therapeutics, Inc.
LRMR
Flynn James E16,973,635
39.2%
10,606increase
(+0.06%)
View
2023-02-27
5:43 pm
Purchase
13GGalera Therapeutics, Inc.
GRTX
Flynn James E2,916,401
4.99%
2,916,401increase
(New Position)
View
2023-02-13
5:28 pm
Purchase
13GPulmonx Corporation
LUNG
Flynn James E2,465,263
6.59%
2,465,263increase
(New Position)
View
2023-02-13
5:03 pm
Sale
13GPulmonx Corporation
LUNG
Flynn James E0
0%
-2,366,867decrease
(Position Closed)
View
2023-02-10
3:59 pm
Sale
13GPhathom Pharmaceuticals, Inc.
PHAT
Flynn James E0
0%
-2,414,897decrease
(Position Closed)
View
2023-02-10
3:57 pm
Unchanged
13GTerns Pharmaceuticals, Inc.
TERN
Flynn James E2,851,287
5.76%
0
(Unchanged)
View
Goto 0, 1, 2, ...14, 15, Next